Gelion – ‘battery development progress update’, attempted ramptastic?

Gelion (GELN) has issued a “GEN 3 Lithium-Sulfur Battery Development Update”-titled announcement commencing that “building on the announcements made in March and April 2024, Gelion has now successfully developed 1 Ah semi-solid-state Li-S pouch cells with its GEN 3 cell technology”. What about this and a current above 4% higher share price response to 25p?

Gelion – emphasises “key technology proof point” milestone achieved. Er, what about that update on “solvency/viability and long-term future”?

Gelion (GELN) has issued an announcement titled “Li-S Cell High Energy Density Milestone Achieved” and the shares have currently responded over 60% higher to 25p. However, that compares to above 24p at which they commenced this year and a 145p per share AIM listing towards the end of 2021. So attempted ramptastic or recovery value?…

Gelion – interims argue “confident… well positioned to continue developing relevant energy storage solutions”. Is it though?…

Describing itself as an “Anglo-Australian battery innovator”, Gelion (GELN) today states that it “is pleased to announce its interim results for the six months ended 31 December 2023” and emphasises “the progress that is being made every day organically by both our Lithium Sulfur and Zinc Hybrid teams to bring the pieces together and establish Gelion's unique proposition”. However, why are the shares then at 15.25p comparing to an even start-of-2024 above 24p?

Gelion – “Result of Retail Offer”, it won’t be funding its losses as much as hoped!

Describing itself as an “Anglo-Australian battery innovator”, Gelion (GELN) earlier this month announced that it “has conditionally agreed to acquire the entire issued share capital of OXLiD for an aggregate consideration of up to approximately £4.2 million… in addition, the company announces a proposed equity fundraising of up to approximately £4.5 million”. With today a “Result of Retail Offer” announcement from the company, what of these developments?

Gelion – announces expanded R&D facility as it “continues to deliver against its go-to-market strategy”. Er, what about the cash burn?...

Gelion (GELN) has issued an “Expanded Li-S R&D Facility launched-titled announcement, emphasising it is “to enable prototyping toward commercial cell development… The new facility is another milestone as Gelion continues to deliver against its go-to-market strategy”. So what of this and a current 24.5p share price?

Gelion – development agreements and “pleased with the progress”, what about the cash burn?

‘Battery innovator’ Gelion (GELN) has issued a “Trading update and two new agreements signed” announcement, and what of the shares remaining down at 24.5p, a £26.6 million market cap, they have recently fallen to?

Gelion (#GELN) – two new development agreements but FY expected even adj. EBITDA loss approx. £6m, net cash £7.3m

Gelion – acquired patent portfolios update, how’s the cash burn?

‘Battery innovator’ Gelion (GELN) states that it “is pleased to provide an update on the strategic evaluation of the Lithium Sulfur ("LiS") and Silicon Anode ("Si") patent portfolios acquired from Johnson Matthey in March” and the shares have currently responded slightly higher to 37.5p. Good news then?